OrganoTherapeutics Companies
OrganoTherapeutics use cutting-edge human-specific mini-brains for the discovery and development of effective drug candidates targeting Parkinson’s disease. We screen new molecules on our proprietary human-specific minibrains which represent a model mimicking faithfully the human Parkinson’s disease pathology.OrganoTherapeutics - Crunchbase Company Profile & Fundingwww.crunchbase.com/organization/organotherapeutics
Technology:
Companies
Industry:
AI R&D Pharma (DPI)
Headquarters:
Italy
Founded Date:
2019
Register and Claim Ownership